Comparison of Lipid Profiles Between Pediatric Living- and Deceased-Donor Liver Recipients
Author | Nima Mehdizadegan | en |
Author | Seyed Mohsen Dehghani | en |
Author | Roya Najafi | en |
Author | Masoud Tahani | en |
Author | Iraj Shahramian | en |
Orcid | Nima Mehdizadegan [0000-0001-6538-1391] | en |
Orcid | Seyed Mohsen Dehghani [0000-0001-5930-0110] | en |
Orcid | Masoud Tahani [0000-0002-0213-9087] | en |
Orcid | Iraj Shahramian [0000-0002-4134-1405] | en |
Issued Date | 2024-05-31 | en |
Abstract | Background: It has been shown that hyperlipidemia occurs in 71% of patients following liver transplantation. Multiple risk factors, including obesity, diabetes mellitus, and diet, as well as the immunosuppressive medications used, influence the lipid profiles that are seen in these individuals, contributing to the multifactorial etiology of lipid problems. Objectives: The aim of the present study is to compare the lipid profile in liver transplant recipients from living-related (LR) and deceased donors (DDs). Methods: This is a retrospective cross-sectional study performed at Shiraz University of Medical Science between 2005 and 2018. Patients under 18 years old who received liver transplants were included in the study and divided into 2 groups who received from LR and DDs, and lipid profiles were compared between the 2 groups. Results: A total of 397 patients were included in the study; in the first group, 234 received a liver from a DD, and in the second group, 161 from an LR donor. The mean body mass index (BMI) was 17.51 ± 5.49 in the first group and 16.25 ± 3.29 in the second group. The most common underlying diseases were biliary atresia (22%) and autoimmune hepatitis (15%). The mean triglyceride (TG) and high-density lipoprotein (HDL) levels were 133 and 46 mg/dL in the first group and 118 and 54 mg/dL in the second group, while the differences were statistically significant. As age increased, there was a significant difference in the mean values of fasting blood sugar (FBS) and HDL, with FBS increasing and HDL decreasing. There was no significant difference in the use of immunosuppressant drugs between the 2 groups. Conclusions: Patients who received a liver from an LR donor have a significantly lower TG, higher HDL, and a lower cardiovascular risk. | en |
DOI | https://doi.org/10.5812/jcp-142461 | en |
Keyword | Hyperlipidemia | en |
Keyword | Immune System | en |
Keyword | Lipid Disorders | en |
Publisher | Brieflands | en |
Title | Comparison of Lipid Profiles Between Pediatric Living- and Deceased-Donor Liver Recipients | en |
Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jcp-15-2-142461.pdf
- Size:
- 110.58 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF